ID

44278

Description

Efficacy and Safety Study of Second-Line Treatment for Hypertension With Autosomal Dominant Polycystic Kidney Disease(ADPKD); ODM derived from: https://clinicaltrials.gov/show/NCT00890279

Link

https://clinicaltrials.gov/show/NCT00890279

Keywords

Versions (2)
  1. 5/12/18 5/12/18 -
  2. 9/20/21 9/20/21 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

September 20, 2021

DOI

To request one please log in.

License

Creative Commons BY 4.0
Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Back to model comments
Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Kidney, Polycystic, Autosomal Dominant NCT00890279

English

Eligibility Kidney, Polycystic, Autosomal Dominant NCT00890279

1 forms  
Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
adpkd patients
Description

Polycystic Kidney Disease, Autosomal Dominant

Data type

boolean

Alias
UMLS CUI [1]
C0085413
blood pressure measured at out-patient setting is above 120/80 mmhg
Description

Blood pressure measurement | Outpatient

Data type

boolean

Alias
UMLS CUI [1]
C0005824
UMLS CUI [2]
C0029921
age between 20 and 60 years old
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
egfr more than 30 ml/min/1.73m2
Description

Estimated Glomerular Filtration Rate

Data type

boolean

Alias
UMLS CUI [1]
C3811844
patients give informed consent
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with severe cardiovascular and hepatic disorders
Description

Cardiovascular Disease Severe | Liver disease Severe

Data type

boolean

Alias
UMLS CUI [1,1]
C0007222
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0023895
UMLS CUI [2,2]
C0205082
patients with complications of central nervous vascular disorders
Description

Central nervous system vascular disorders Complications

Data type

boolean

Alias
UMLS CUI [1,1]
C0851452
UMLS CUI [1,2]
C0009566
women who are breast feeding and females of childbearing potential who are not using acceptable contraceptive methods
Description

Breast Feeding | Childbearing Potential Contraceptive methods Absent

Data type

boolean

Alias
UMLS CUI [1]
C0006147
UMLS CUI [2,1]
C3831118
UMLS CUI [2,2]
C0700589
UMLS CUI [2,3]
C0332197
patients currently engaging in other experimental protocol
Description

Study Subject Participation Status

Data type

boolean

Alias
UMLS CUI [1]
C2348568
patients with intracranial aneurysma
Description

Intracranial Aneurysm

Data type

boolean

Alias
UMLS CUI [1]
C0007766
patients who must use diuretics
Description

Patient need for Diuretics

Data type

boolean

Alias
UMLS CUI [1,1]
C0686904
UMLS CUI [1,2]
C0012798
allergic patients to candesartan or cilnidipine
Description

Hypersensitivity Candesartan | Hypersensitivity Cilnidipine

Data type

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0717550
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C0378675
patients whose hypertension is not controlled by medication of this protocol
Description

Hypertensive disease Control | Pharmaceutical Preparations Study Protocol Absent

Data type

boolean

Alias
UMLS CUI [1,1]
C0020538
UMLS CUI [1,2]
C0243148
UMLS CUI [2,1]
C0013227
UMLS CUI [2,2]
C2348563
UMLS CUI [2,3]
C0332197
Back to the top of the page

Similar models

Eligibility Kidney, Polycystic, Autosomal Dominant NCT00890279

1 forms
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Polycystic Kidney Disease, Autosomal Dominant
Item
adpkd patients
boolean
C0085413 (UMLS CUI [1])
Blood pressure measurement | Outpatient
Item
blood pressure measured at out-patient setting is above 120/80 mmhg
boolean
C0005824 (UMLS CUI [1])
C0029921 (UMLS CUI [2])
Age
Item
age between 20 and 60 years old
boolean
C0001779 (UMLS CUI [1])
Estimated Glomerular Filtration Rate
Item
egfr more than 30 ml/min/1.73m2
boolean
C3811844 (UMLS CUI [1])
Informed Consent
Item
patients give informed consent
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Cardiovascular Disease Severe | Liver disease Severe
Item
patients with severe cardiovascular and hepatic disorders
boolean
C0007222 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0023895 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Central nervous system vascular disorders Complications
Item
patients with complications of central nervous vascular disorders
boolean
C0851452 (UMLS CUI [1,1])
C0009566 (UMLS CUI [1,2])
Breast Feeding | Childbearing Potential Contraceptive methods Absent
Item
women who are breast feeding and females of childbearing potential who are not using acceptable contraceptive methods
boolean
C0006147 (UMLS CUI [1])
C3831118 (UMLS CUI [2,1])
C0700589 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Study Subject Participation Status
Item
patients currently engaging in other experimental protocol
boolean
C2348568 (UMLS CUI [1])
Intracranial Aneurysm
Item
patients with intracranial aneurysma
boolean
C0007766 (UMLS CUI [1])
Patient need for Diuretics
Item
patients who must use diuretics
boolean
C0686904 (UMLS CUI [1,1])
C0012798 (UMLS CUI [1,2])
Hypersensitivity Candesartan | Hypersensitivity Cilnidipine
Item
allergic patients to candesartan or cilnidipine
boolean
C0020517 (UMLS CUI [1,1])
C0717550 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C0378675 (UMLS CUI [2,2])
Hypertensive disease Control | Pharmaceutical Preparations Study Protocol Absent
Item
patients whose hypertension is not controlled by medication of this protocol
boolean
C0020538 (UMLS CUI [1,1])
C0243148 (UMLS CUI [1,2])
C0013227 (UMLS CUI [2,1])
C2348563 (UMLS CUI [2,2])
C0332197 (UMLS CUI [2,3])
Back to the top of the page 

Contact

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial